Common Stock, Shares, Outstanding of Kiromic Biopharma, Inc. from 31 Dec 2019 to 31 Dec 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Kiromic Biopharma, Inc. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2019 to 31 Dec 2024.
  • Kiromic Biopharma, Inc. Common Stock, Shares, Outstanding for the quarter ending 31 Dec 2024 was 1,533,272, a 22% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

Kiromic Biopharma, Inc. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 1,533,272 +274,812 +22% 31 Dec 2024 10-K 14 Feb 2025 2024 FY
Q3 2024 1,545,920 +369,660 +31% 30 Sep 2024 10-Q 08 Nov 2024 2024 Q3
Q2 2024 1,542,420 +366,160 +31% 30 Jun 2024 10-Q 09 Aug 2024 2024 Q2
Q1 2024 1,288,235 +308,992 +32% 31 Mar 2024 10-Q 10 May 2024 2024 Q1
Q4 2023 1,258,460 +610,076 +94% 31 Dec 2023 10-K 14 Feb 2025 2024 FY
Q3 2023 1,176,260 -14,666,931 -93% 30 Sep 2023 10-Q 14 Nov 2023 2023 Q3
Q2 2023 1,176,260 -14,662,852 -93% 30 Jun 2023 10-Q 14 Aug 2023 2023 Q2
Q1 2023 979,243 -14,606,344 -94% 31 Mar 2023 10-Q 15 May 2023 2023 Q1
Q4 2022 648,384 +132,100 +26% 31 Dec 2022 10-K 19 Mar 2024 2023 FY
Q3 2022 15,843,191 +365,673 +2.4% 30 Sep 2022 10-Q 14 Nov 2022 2022 Q3
Q2 2022 15,839,112 +8,451,612 +114% 30 Jun 2022 10-Q 12 Aug 2022 2022 Q2
Q1 2022 15,585,587 +8,252,588 +113% 31 Mar 2022 10-Q 13 May 2022 2022 Q1
Q4 2021 516,284 -6,816,715 -93% 31 Dec 2021 10-K 17 Apr 2023 2022 FY
Q3 2021 15,477,518 +10,488,249 +210% 30 Sep 2021 10-Q 11 Mar 2022 2021 Q3
Q2 2021 7,387,500 30 Jun 2021 10-Q 13 Aug 2021 2021 Q2
Q1 2021 7,332,999 31 Mar 2021 10-Q 14 May 2021 2021 Q1
Q4 2020 7,332,999 +4,469,187 +156% 31 Dec 2020 10-K 08 Apr 2022 2021 FY
Q3 2020 4,989,269 30 Sep 2020 10-Q 30 Nov 2020 2020 Q3
Q4 2019 2,863,812 31 Dec 2019 10-K 31 Mar 2021 2020 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.